Relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients

Cyclosporine is the main immunosuppressive drug used for renal transplant reci-pients in order to prevent transplant rejection. Although the drug has increased the survival of patients and grafted organ, it has some side effects independent of its effect on the immune system. This study was done to evaluate the effect of cyclosporine on serum Mg level and its metabolic side effects in renal allograft patients. 157 (62 female and 95 male) renal transplant recipients treated with cyclosporine to prevent transplant rejection were included in the study. Clinical and biochemical data along with cyclosporine levels was documented. Mean serum Mg level was 196 ± 0.31 mg/dL and mean serum cyclosporine level was 371 ± 192 µg/dL. Hypomagnesemia was detected in 16 (10.2%) with a negative significant correlation with cyclosporine levels, serum creatinine, plasma LDL, fasting Blood sugar and uric acid. In conclusion according to the results of this study there is a significant correlation between cyclosporine and hypomagnesemia. Therefore, routine measurement of serum Mg and its treatment seems necessary to prevent its complications

Serum CRP levels in pre-dialysis patients

Background. An elevated serum C-reactive protein (CRP) is strongly associated with morbidity and mortality in dialysis patients. However, the significance of high CRP levels in pre-dialysis patients has not been studied extensively. The aim of this study was to determine the prevalence of elevated serum CRP in pre-dialysis patients and to analyze its correlation with renal function and other inflammatory and nutritional factors. Methods. In a cross-sectional study, 100 pre-dialysis patients who had been visited in two outpatient nephrology clinics from 2005 until 2006 and had the serum creatinine >= 1.5 mg/dL for at least three months were studied. Demographic characteristics, medications, GFR, hemoglobin, as well as inflammatory and nutritional parameters (CRP, Albumin, Fibrinogen, Transferin, Ferritin, TG, Chol, LDL, and HDL) were measured and compared between the patients in regard to the CRP level. Results. The mean of serum CRP level was 5.7 +/- 5.1 mg/L; elevated level were reported in 17 patients (17%). Serum CRP levels was significantly correlated with GFR, albumin, fibrinogen, transferring, and ferritin. Conclusion. Similar to the dialysis population, we found that serum CRP was elevated in pre-dialysis patients. In addition, a positive correlation between serum CRP levels and several inflammatory factors was found. CRP serum level was also negatively correlated with GFR, the indicator of renal function